🇺🇸 FDA
Pipeline program

Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Placebo to match LY3298176 injection

I8F-MC-GPIX

Phase 3 small_molecule active

Quick answer

Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Placebo to match LY3298176 injection for Obesity is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).

Program details

Company
Eli Lilly Co.
Indication
Obesity
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials